Clinical Trials
2 trialsNCT06788912 2026-05-26
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT07103395 2026-01-14
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Recruiting